Atrial peptides modify the effect of marinobufagenin on sodium pumps: implications for blood pressure control.
Buckalew
Vardaman M
VM
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002018:Bufanolides / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006325:Heart Atria; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D051379:Mice; D009318:Natriuresis / Q000502:physiology; D045283:Natriuretic Agents / Q000502:physiology; D010455:Peptides / Q000502:physiology*; D010949:Plasma / Q000502:physiology; D000254:Sodium-Potassium-Exchanging ATPase / Q000187:drug effects* / Q000502:physiology
D002018:Bufanolides; D004791:Enzyme Inhibitors; D045283:Natriuretic Agents; D010455:Peptides; C093896:marinobufagenin; D000254:Sodium-Potassium-Exchanging ATPase